List of IQVIA FIA Customers
Cambridge, CB4 0WG,
United Kingdom
Since 2010, our global team of researchers has been studying IQVIA FIA customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased IQVIA FIA for Insurance Claims Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using IQVIA FIA for Insurance Claims Management include: Bristol-Myers Squibb United States, a United States based Life Sciences organisation with 32000 employees and revenues of $46.30 billion, Novo Nordisk, a Denmark based Life Sciences organisation with 78554 employees and revenues of $45.92 billion, Bausch Health, a Canada based Life Sciences organisation with 20700 employees and revenues of $9.63 billion, ViiV Healthcare USA, a United States based Life Sciences organisation with 800 employees and revenues of $200.0 million and many others.
Contact us if you need a completed and verified list of companies using IQVIA FIA, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The IQVIA FIA customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bausch Health | Life Sciences | 20700 | $9.6B | Canada | IQVIA | IQVIA FIA | Insurance Claims Management | 2022 | n/a |
In 2022, Bausch Health used IQVIA FIA for Insurance Claims Management to support US-facing pharmacy and patient access communications for VYZULTA. The deployment is evidenced by a published pharmacy flashcard that cites IQVIA FIA data covering Dec 2021 to Nov 2022 for coverage and approval metrics.
IQVIA FIA was used as a source of coverage, approval rate, and copay outcome metrics, indicating configuration of Insurance Claims Management capabilities to report payer authorization and copay patterns. The materials reference Medicare and commercial approval rates and copay outcomes, which aligns with typical claims adjudication analytics and payer coverage reporting within the Insurance Claims Management category.
Operationally the use is concentrated in the United States, and the data was surfaced in pharmacy resolution and patient access collateral, showing direct consumption by pharmacy and patient access teams for external and provider-facing materials. The citation of IQVIA FIA in published collateral demonstrates that claims-derived coverage analytics were operationalized into market access and patient support communications rather than being restricted to internal analysis.
The public reference to IQVIA FIA as the data source implies governance controls for sourcing claims coverage datasets into promotional and patient access documentation, and it signals a structured process for translating Insurance Claims Management outputs into payer-facing and pharmacy-facing messaging.
|
 |
Bristol-Myers Squibb United States | Life Sciences | 32000 | $46.3B | United States | IQVIA | IQVIA FIA | Insurance Claims Management | 2025 | n/a |
In 2025 Bristol-Myers Squibb United States deployed IQVIA FIA to power its COBENFY US prescription coverage and out of pocket estimate capabilities. The deployment positions IQVIA FIA as an Insurance Claims Management platform supporting market access and patient access workflows while surfacing claims approval and out of pocket distribution metrics for web‑facing coverage lookup and estimates.
IQVIA FIA is configured to deliver payer and adjudication analytics, claims approval reporting, and out of pocket calculation services that feed the COBENFY coverage tool. Functional capabilities implemented include claims approval metrics, out of pocket distribution reporting, and coverage determination logic aligned to payer adjudication analytics typical of Insurance Claims Management systems.
The implementation integrates IQVIA FIA outputs into the COBENFY US prescription coverage and out of pocket estimates workflow, with the COBENFY coverage tool citing IQVIA FIA for claims approval and out of pocket distribution metrics for the latest 4 weeks ending 03/28/2025. Operational coverage is focused on US market access and patient access teams and on reporting use cases where payer adjudication visibility is required.
Governance is centered on operationalizing FIA driven analytics within market access and patient access reporting processes, enabling consistent claim approval and out of pocket statistics to be consumed by the COBENFY tool and related reporting pipelines. IQVIA FIA is explicitly used for payer adjudication analytics in the US market and for driving the COBENFY prescription coverage and out of pocket estimate outputs.
|
 |
Novo Nordisk | Life Sciences | 78554 | $45.9B | Denmark | IQVIA | IQVIA FIA | Insurance Claims Management | 2016 | n/a |
In 2016 Novo Nordisk implemented IQVIA FIA as part of its Insurance Claims Management capability. The implementation was embedded in the companys broader cloud analytics and CRM program under the Team Lead for Data Analytical, CRM & Integration, with a clear focus on supporting Commercial Effectiveness, Sales and Marketing, and Medical functions.
IQVIA FIA was configured to ingest payer and claims level datasets for Insurance Claims Management and to feed the cloud warehouse ecosystem comprising a Data Lake, Amazon RedShift warehouse and a data visualization layer. Configuration emphasized claims level attribution, formulary insights and physician influence data to support call planning, targeting and self service field reporting for performance sales and Veeva CRM field activity.
The deployment integrated IQVIA FIA feeds with Veeva CRM and a unified Vault content repository for promotional and medical content, and correlated FIA data with third party datasets including Xponent Plantrak Weekly, LRx Weekly, DDD data sets, PDRP Opt outs, AMA No contacts, HCOS, HCPS, Specialty Pharmacy data, Fingertip Formulary and influence metrics. These integrated datasets populated the RedShift warehouse and BI layer to enable alignment of field activity, account targeting and roster allocation across IDN, health systems, managed care and specialty channels.
Governance workstreams defined business rules for alignment, overlay, call plan apportionment, targeting and incentive compensation related changes for the data warehouse and Veeva Align, and detailed CRM process maps for migration and analytics requirements. Rollout priorities focused on operationalizing self service analytics for field reps and central commercial teams, and consolidating claims intelligence into existing CRM driven workflows.
|
 |
|
Life Sciences | 800 | $200M | United States | IQVIA | IQVIA FIA | Insurance Claims Management | 2023 | n/a |
|
Buyer Intent: Companies Evaluating IQVIA FIA
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||